Pharmaceutical companies are "all over the map" in terms of their environmental goals and transparency, but largely don't set targets for their supply chains, according to a new report.
Green Research found that major pharmaceutical companies have between five and six public environmental sustainability goals, each on average. AstraZeneca leads with 12, while Merck brings up the rear with one.
There is also much qualitative variation between the goals, Green Research said. "Aggressive goals are more powerful than modest goals. Public goals have greater impact than internal goals. Quantitative goals are more credible than non-quantitative goals. And goals for the future send a signal that goals described in retrospect do not."
